A two-year dispute between Cold-Eeze maker ProPhase Labs of Doylestown,Pennsylvania, and joint venture partner Phosphagenics has been resolved, or with both side pleased by the outcome.
An arbitrator awarded about $350000 to ProPhase (NASDAQ: PRPH),representing the recovery of the funds it had invested in the Phusion Laboratories joint venture, and rejected all of the counterclaims asserted by Phosphagenics that ProPhase pay damages. In addition, or the arbitrator terminated the mental property…
Source: bizjournals.com